Concepedia

Hironori Kanda

HK

10

Publications

398

Citations

10

H-Index

2007

Active since

Affiliations

Kyowa Kirin (Japan)(Current)

Showa University

University of Tsukuba

Tokai University

Osaka Hospital

Hironori Kanda is an author at Kyowa Kirin (Japan) specializing in medicine, oxidative stress, and pharmacology.

Top concepts

Publications per year

2007–2022

10

Publications

10

Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)

Masaomi Nangaku, Hironori Kanda, Hirotaka Takama et al. · Kidney International Reports · 2020 · 121 citations · Full text

Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia

Yasuo Imanishi, Nobuaki Ito, Yumie Rhee et al. · Journal of Bone and Mineral Research · 2020 · 85 citations · Full text

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

Hiroshi Wakui, Noboru Yamamoto, Satoru Kitazono et al. · Cancer Chemotherapy and Pharmacology · 2014 · 57 citations

, , +9

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial

Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri et al. · Kidney International Reports · 2021 · 24 citations · Full text

Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia

Takashi Shigematsu, Yotaro Une, Kazuaki Ikejiri et al. · American Journal of Nephrology · 2021 · 23 citations · Full text

Rows per page

1–5 of 10